Phibro outlines FY2026 net sales of $1.46B-$1.5B as adjusted EBITDA guidance moves to $247M-$255M
Phibro Animal Health Corporation Class A · PHARMACEUTICAL PREPARATIONS · Now $29.87
-15% in 7d after detection
Post-detection moves
1h
—
1d
-9.2%
3d
-12%
7d
-15%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS